Cargando…
Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension
Sodium-glucose transporter 2 (SGLT2) inhibitors are new glucose-lowering agents that have been proven to be beneficial for patients with cardiovascular diseases, heart failure, and sudden cardiac death. However, the possible protective effects of cardiac arrhythmia have not yet been clarified in cli...
Autores principales: | Jhuo, Shih-Jie, Lin, Tsung-Hsien, Lin, Yi-Hsiung, Tsai, Wei-Chung, Liu, I-Hsin, Wu, Bin-Nan, Lee, Kun-Tai, Lai, Wen-Ter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880188/ https://www.ncbi.nlm.nih.gov/pubmed/35207759 http://dx.doi.org/10.3390/jpm12020271 |
Ejemplares similares
-
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling
por: Jhuo, Shih-Jie, et al.
Publicado: (2023) -
Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor
por: Jhuo, Shih-Jie, et al.
Publicado: (2020) -
Effects of Trans, Trans-2,4-decadienal on the Ions Currents of Cardiomyocytes: Possible Mechanisms of Arrhythmogenesis Induced by Cooking-oil Fumes
por: Jhuo, Shih-Jie, et al.
Publicado: (2020) -
Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin
por: Jhuo, Shih-Jie, et al.
Publicado: (2021) -
Association of Increased Arterial Stiffness and P Wave Dispersion with Left Ventricular Diastolic Dysfunction
por: Tsai, Wei-Chung, et al.
Publicado: (2013)